Adeptus Health (ADPT) Misses Q4 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Needham Starts NeoVolta (NEOV) at Buy
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Adeptus Health (ADPT) PT Raised to $46 at Piper Jaffray on Solid Q4
February 20, 2015 9:00 AM ESTPiper Jaffray analyst Kevin Ellich reiterated an Overweight rating and boosted his price target on Adeptus Health (NYSE: ADPT) to $46.00 (from $45.00) following solid Q4 results.
Ellich commented, "ADPT reported solid Q4 results despite a negative impact from lower volumes in the... More
